Cardiac Resynchronization Therapy (CRT) is a cutting-edge medical intervention designed to improve the heart's efficiency in individuals with heart failure. This specialized therapy involves the implantation of a device, often a pacemaker, which coordinates the contractions of the heart's ventricles. In heart failure patients, the synchronization of these contractions can be disrupted, leading to reduced cardiac output. CRT helps address this issue by precisely timing electrical impulses to optimize the heart's pumping ability, thereby enhancing blood flow and overall cardiovascular function. This therapy has proven to be a game-changer for many patients, alleviating symptoms, improving exercise tolerance, and enhancing their overall quality of life. As a result, Cardiac Resynchronization Therapy continues to be at the forefront of innovative approaches in managing heart failure and promoting cardiac well-being.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain